影像導引注射藥物市場規模、佔有率和成長分析：按成像方法、應用、注射藥物類型、最終用戶、治療類型和地區分類－2026-2033年產業預測

2024 年全球影像導引注射藥物市場價值為 28.6 億美元，預計到 2025 年將成長至 31.1 億美元，到 2033 年將成長至 61.7 億美元，在預測期（2026-2033 年）內複合年成長率為 8.9%。

由於成本效益的提高和極具吸引力的保險報銷獎勵，影像導引注射藥物市場正蓬勃發展，醫院和門診診所的採用率也隨之提高。保險報銷率的提高鼓勵醫療機構投資超音波和CT導航技術，從而縮短患者住院時間並減少再次治療。特別是在脊椎疼痛治療領域，向一次性支付模式的轉變刺激了對透視引導下硬膜外類固醇注射及相應給藥裝置的需求。隨著醫療產業向價值醫療模式轉型，開發整合劑量控制和即時分析功能的導管的製造商預計將獲得顯著的市場佔有率。這個不斷成長的市場涵蓋了能夠提高美容、整形外科和腫瘤手術精準度的器械和藥物製劑，從而顯著降低手術風險並改善患者預後。

全球影像導引注射藥物市場的成長要素

人們對能夠最大限度減少不適、縮短恢復時間並獲得顯著療效的治療方案的需求日益成長，這極大地推動了影像引導注射技術的應用。患者越來越傾向於選擇兼顧療效和便利性的治療方案，這促使醫療機構採用先進技術，以確保精準給藥並最大限度地減少組織損傷。這一趨勢不僅提高了患者滿意度，也促進了重複治療，從而推動了市場成長，因為醫療機構正在擴大服務範圍以滿足不斷變化的消費者需求。此外，人們對自然美觀效果的追求也進一步提升了利用影像技術確保最佳注射位置和劑量的標靶注射技術的吸引力。

全球影像導引注射劑市場的限制因素

由於注射劑產品的安全性和有效性受到嚴格的法規結構，全球影像導引注射藥物市場面臨許多挑戰。這些法規要求進行廣泛的上市前測試和持續的上市後監測，迫使製造商應對複雜的核准流程。這通常涉及收集大量的臨床證據並遵守嚴格的品質標準，從而導致研發週期延長和營運成本增加。這些挑戰阻礙了新進入者，並限制了創新製劑的市場推廣。因此，相關人員往往優先考慮合規性而非產品差異化和積極的市場進入，最終阻礙了市場成長。

全球影像導引注射藥物市場趨勢

全球影像導引注射藥物市場正經歷動態變化，這主要得益於人工智慧技術與診斷成像技術的融合。利用機器學習演算法對超音波和CT影像進行即時分析，正在革新注射技術，使臨床醫生能夠更精準地確定最佳注射部位和劑量。這項創新顯著降低了操作差異，簡化了治療流程，提高了病人安全性，與日益成長的精準醫療理念相契合。隨著醫療機構擴大採用人工智慧驅動的工作流程，將預測分析技術整合到注射設備中，不僅提高了效率和成本效益，也推動了美容和治療領域全球市場的擴張。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場分析

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場魅力指數
• PESTLE分析
• 監理情勢

全球影像導引注射藥物市場規模：以成像方式分類

• 超音波引導
• CT引導型
• 透明度指南類型
• 磁共振引導

全球影像導引注射藥物市場規模：按應用領域分類

• 疼痛管理
• 整形外科
• 腫瘤學
• 風濕病學

全球影像導引注射藥物市場規模：依注射藥物類型分類

• 皮質類固醇
• 玻尿酸
• 生物製劑
• 局部麻醉劑

全球影像導引注射藥物市場規模：依最終用戶分類

• 醫院
• 專科診所
• 門診手術中心

全球影像導引注射藥物市場規模：依手術類型分類

• 診斷
• 治療

全球影像導引注射藥物市場規模：按地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲國家

競爭資訊

• 前五大公司對比
• 主要公司2025年的市場定位
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市場占有率分析，2025 年
• 主要公司的完整公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 銷售收入年比比較（2023-2025 年）

主要公司簡介

• GE HealthCare Technologies Inc.
• Siemens Healthineers AG
• Philips NV
• Canon Medical Systems Corporation
• FUJIFILM Holdings Corporation
• Samsung Medison Co., Ltd.
• Hologic, Inc.
• Bracco Imaging SpA
• Bayer AG
• Merit Medical Systems, Inc.
• Boston Scientific Corporation
• Becton, Dickinson and Company
• Cook Medical LLC
• Medtronic plc
• Terumo Corporation
• Argon Medical Devices, Inc.
• Stryker Corporation
• Zimmer Biomet Holdings, Inc.
• Esaote SpA
• Koninklijke Philips NV

結論與建議

Global Image-Guided Injectables Market size was valued at USD 2.86 Billion in 2024 and is poised to grow from USD 3.11 Billion in 2025 to USD 6.17 Billion by 2033, growing at a CAGR of 8.9% during the forecast period (2026-2033).

The image-guided injectables market is gaining traction due to enhanced cost efficiency and attractive reimbursement incentives, leading to broader adoption in hospitals and outpatient clinics. Increased reimbursement levels encourage providers to invest in ultrasound and CT navigation technologies, resulting in shorter patient stays and fewer repeat procedures. Notably, the shift towards bundled payment models for spinal pain has spurred demand for fluoroscopy-guided epidural steroid injections and compatible delivery devices. As the industry transitions to value-based care, manufacturers that develop catheters with integrated dose control and real-time analytics stand to gain substantial market share. This growing market encompasses devices and drug formulations for improved accuracy in aesthetic, orthopedic, and oncological procedures, significantly reducing procedural risks and enhancing patient outcomes.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Image-Guided Injectables market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Image-Guided Injectables Market Segments Analysis

Global image-guided injectables market is segmented by imaging modality, application, injectable type, end user, procedure type and region. Based on imaging modality, the market is segmented into ultrasound-guided, CT-guided, fluoroscopy-guided and MRI-guided. Based on application, the market is segmented into pain management, orthopedics, oncology and rheumatology. Based on injectable type, the market is segmented into corticosteroids, hyaluronic acid, biologics and local anesthetics. Based on end user, the market is segmented into hospitals, specialty clinics and ambulatory surgical centers. Based on procedure type, the market is segmented into diagnostic and therapeutic. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Image-Guided Injectables Market

The rising demand for procedures that provide effective results with minimal discomfort and shorter recovery periods is significantly boosting the use of image-guided injectables. Patients are increasingly looking for treatments that prioritize both results and convenience, which encourages healthcare providers to implement advanced technologies that ensure precise delivery and minimize tissue damage. This trend not only enhances patient satisfaction but also leads to repeat engagements, fostering market growth as providers diversify their services to align with changing consumer needs. Additionally, the preference for natural-looking results further amplifies the attractiveness of targeted injections, which utilize imaging for optimal placement and dosage.

Restraints in the Global Image-Guided Injectables Market

The Global Image-Guided Injectables market faces significant obstacles due to stringent regulatory frameworks that dictate the safety and efficacy of injectable products. These regulations necessitate extensive pre-market testing and ongoing post-marketing surveillance, obliging manufacturers to navigate complex approval processes. This often involves gathering substantial clinical evidence and adhering to strict quality standards, leading to prolonged development timelines and elevated operational costs. Such challenges deter new entrants and restrict the introduction of innovative formulations into the market. As a result, stakeholders tend to allocate resources toward compliance rather than product differentiation or aggressive market penetration, ultimately hindering market growth.

Market Trends of the Global Image-Guided Injectables Market

The Global Image-Guided Injectables market is witnessing a dynamic shift driven by the integration of AI technologies into imaging modalities. The utilization of machine learning algorithms for real-time interpretation of ultrasound and CT imagery is revolutionizing injection techniques, enabling clinicians to identify optimal entry points and dosage with heightened accuracy. This innovation significantly minimizes procedural variability, streamlines treatment cycles, and bolsters patient safety, aligning with the growing emphasis on precision medicine. As healthcare facilities increasingly adopt AI-enhanced workflows, the incorporation of predictive analytics into injection devices not only fosters efficiency and cost-effectiveness but also expands the market's global reach across both cosmetic and therapeutic domains.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Image-Guided Injectables Market Size by Imaging Modality & CAGR (2026-2033)

• Market Overview
• Ultrasound-Guided
• CT-Guided
• Fluoroscopy-Guided
• MRI-Guided

Global Image-Guided Injectables Market Size by Application & CAGR (2026-2033)

• Market Overview
• Pain Management
• Orthopedics
• Oncology
• Rheumatology

Global Image-Guided Injectables Market Size by Injectable Type & CAGR (2026-2033)

• Market Overview
• Corticosteroids
• Hyaluronic Acid
• Biologics
• Local Anesthetics

Global Image-Guided Injectables Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Specialty Clinics
• Ambulatory Surgical Centers

Global Image-Guided Injectables Market Size by Procedure Type & CAGR (2026-2033)

• Market Overview
• Diagnostic
• Therapeutic

Global Image-Guided Injectables Market Size & CAGR (2026-2033)

• North America (Imaging Modality, Application, Injectable Type, End User, Procedure Type)
  • US
  • Canada
• Europe (Imaging Modality, Application, Injectable Type, End User, Procedure Type)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Imaging Modality, Application, Injectable Type, End User, Procedure Type)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Imaging Modality, Application, Injectable Type, End User, Procedure Type)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Imaging Modality, Application, Injectable Type, End User, Procedure Type)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• GE HealthCare Technologies Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Philips N.V.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Canon Medical Systems Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• FUJIFILM Holdings Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Samsung Medison Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hologic, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bracco Imaging S.p.A.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bayer AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merit Medical Systems, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cook Medical LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Argon Medical Devices, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stryker Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zimmer Biomet Holdings, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Esaote S.p.A.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Koninklijke Philips N.V.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations